Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Children With Irritable Bowel Syndrome
NCT07914478Recruiting
- Sponsor
- Aziz Bhatti Shaheed Teaching Hospital
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in irritable bowel syndrome (IBS) and Vitamin D deficiency (VDD) comparing Group A - Vitamin D3 with Group B - Placebo (2 arms). Primary endpoint: Irritable Bowel Syndrome Symptom Severity at 12 weeks. Started Sep 2026; status: recruiting.
02
Drugs
vitamin d
03
Conditions
irritable bowel syndrome (IBS)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT07914478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914478.